What started as a routine magnet fishing trip quickly turned dark. I pulled something up that I never expected—and honestly ...

Deep within a remote forest in China, a World War II aircraft was discovered abandoned and untouched for decades. This ...

With more than $270 billion in commitments to date, a new wave of pharmaceutical manufacturing is slated to hit the US. At least, that’s what the industry is trying to project. Behind the ...

For the pharma industry, the question becomes: How can we properly prepare for reshoring while ensuring we're building tomorrow's manufacturing infrastructure today?

Big pharma, big investments If Trump’s aim was to at least attract investment into the US pharmaceutical manufacturing sector, then the President can tick that box. Drugmakers have poured ...

Precisely, the FDA should be able to approve pharmaceutical manufacturing plants in the US faster by removing certain requirements, streamlining reviews, and providing both extra and early support.

German packaging and technology specialist Schott created Schott Pharma as a standalone business for its drug packaging unit back in 2022. Schott Pharma flew solo for roughly a year before listing ...

Our Methodology We sifted through stock screeners, financial media reports, and ETFs to compile a list of 25 best pharma stocks and then chose the top 12 with the highest number of hedge fund ...

The pharma sector stocks are in the red after the new executive orders that US President Donald Trump signed last evening in a bid to encourage domestic manufacturing in the United States.

Bristol Myers Squibb is yet another example of a Big Pharma company pledging a multibillion dollar investment in the U.S. as the Trump administration tries to woo drugmakers to boost their domestic ...

The order asks the FDA to reduce the time it takes to approve domestic manufacturing plants Anna Moneymaker/Getty Images By Ed Silverman May 5, 2025 Pharmalot Columnist, Senior Writer ...